Followers

Tuesday, September 15, 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...

from NDTV News - Topstories https://ift.tt/35BsWI9

No comments:

Post a Comment

RBI redistributes portfolios as Patra retires as dy guv

from Business News: Business News, Business News Today, Latest Business News, Stock Markets, Financial News, India Business & World Bu...